Twitter Inc (NYSE:TWTR) has considered buying online music services SoundCloud and Spotify in recent months, suggesting the company wants to make a large acquisition to find a new source of revenue growth, according to the Financial Times. The company has been trying to increase the time users spend using its app, as its shares have nearly halved in value from a year ago, the Financial Times said, citing three people familiar with the matter. Twitter’s own music app, Twitter Inc (NYSE:TWTR) net profit margin is -93.70% and weekly performance is -2.58%. On last trading day company shares ended up $32.90. Analysts mean target price for the company is $43.69. Twitter Inc (NYSE:TWTR) distance from 50-day simple moving average (SMA50) is -15.78%.
Lululemon Athletica inc. (NASDAQ:LULU) was upgraded by investment analysts at Sterne Agee from an “underperform” rating to a “neutral” rating in a note issued to investors on Thursday, TheFlyOnTheWall.comreports. The analysts noted that the move was a valuation call. Lululemon Athletica inc. (NASDAQ:LULU) shares fell -0.67% in last trading session and ended the day on $42.98. Gross Margin is 52.80% and its return on assets is 28.50%. Lululemon Athletica inc. (NASDAQ:LULU) quarterly performance is -13.83%.
Halozyme Therapeutics Inc. (NASDAQ:HALO) ran up 14% after the company said the U.S. Food and Drug Administration removed the hold on patient enrollment in the later-stage trial of the company’s treatment for pancreatic cancer. Halozyme Therapeutics, Inc. (NASDAQ:HALO) shares moved up 2.41% in last trading session and was closed at $8.08, while trading in range of $7.73- $8.09. Halozyme Therapeutics, Inc. (NASDAQ:HALO) year to date (YTD) performance is -46.10%.
Rite Aid Corporation (NYSE:RAD) today announced sales results for May. The Company also provided preliminary estimated financial results for the quarter ended May 31, 2014 and updated its outlook for 2015 fiscal year. For the five weeks ended May 31, 2014, same store sales increased 3.5 percent over the prior-year period. May front-end same store sales increased 0.5 percent. Pharmacy same store sales, which included an approximate 156 basis points negative impact from new generic introductions, increased 5.0 percent. Prescription count at comparable stores increased 3.2 percent over the prior-year period. Rite Aid Corporation (NYSE:RAD) ended the last trading day at $8.50. Company weekly volatility is calculated as 2.50% and price to cash ratio as 56.42. Rite Aid Corporation (NYSE:RAD) showed a positive weekly performance of 2.29%.
Clovis Oncology Inc (NASDAQ:CLVS) was downgraded by equities researchers at Citigroup Inc. from a “buy” rating to a “neutral” rating in a research report issued on Tuesday, TheFlyOnTheWall.com reports. They currently have a $53.00 target price on the stock, down from their previous target price of $109.00. Citigroup Inc.’s price target suggests a potential upside of 38.02% from the stock’s previous close.
Clovis Oncology Inc (NASDAQ:CLVS) weekly performance is -21.60%. On last trading day company shares ended up $38.40. Analysts mean target price for the company is $98.63. Clovis Oncology Inc (NASDAQ:CLVS) distance from 50-day simple moving average (SMA50) is -33.47%.